The aim of the study was to identify the rates and the predictors of long-term remission and the recurrence of type 2 diabetes mellitus (T2DM) after Roux-en-Ygastric bypass (RYGBP) or sleeve gastrectomy (SG). 75.2% of subjects presented with remission of T2DM lasting at least 12 months. Regression analysis showed a longer history of T2DM, a higher presurgical glycated hemoglobin level and insulin treatment at baseline as independent predictors for the lack of T2DM remission. Insulin use before surgery, an older age, and weight regain after remission predicted recurrence of the disease.
Annals of Surgery 2012;doi: 10.1097/SLA.0b013e318262ee6b
Headline: Insufficient weight loss or weight regain hamper the surgical benefits of bariatric surgery on T2DM
OnSurg thanks the editors at School of Surgery for making their current surgical literature summaries available to the world. School of Surgery tweets at @schoolofsurgery and maintains a Facebook fan page here.
